Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07740538
Malnutrition and Sarcopenia Among Primary Ciliary DyskinesiaIzmir Democracy UniversityNot Yet Recruiting
NCT07740538Not Yet Recruiting
—
Malnutrition and Sarcopenia Among Primary Ciliary DyskinesiaIzmir Democracy Universit...
NCT07739407
Ultrasound-Guided PECS II Block for Permanent Pacemaker Implantationferdi gülaştıNot Yet RecruitingNot Applicable
NCT07739407Not Yet Recruiting
Not Applicable
Ultrasound-Guided PECS II Block for Permanent Pacemaker Implantationferdi gülaştı
NCT07739420
A Randomized, Assessor-Blinded, Intraindividual Study on the Efficacy of Fractional Carbon Dioxide Laser Versus Long-Pulsed 1064 nm Nd:YAG Laser in the Treatment of Keratosis PilarisJose R. Reyes Memorial Medical CenterCompletedNot Applicable
NCT07739420Completed
Not Applicable
A Randomized, Assessor-Blinded, Intraindividual Study on the Efficacy of Fractio...Jose R. Reyes Memorial Me...
NCT07738809
Effects of Exercise Intervention on Sleep Quality and Emotional Problems in College Students With Depressive SymptomsCapital University of Physical Education and Sports, ChinaNot Yet RecruitingNot Applicable
NCT07738809Not Yet Recruiting
Not Applicable
Effects of Exercise Intervention on Sleep Quality and Emotional Problems in Coll...Capital University of Phy...
NCT07740655
Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation After Nasal SurgeryJeju National University School of MedicineNot Yet RecruitingPhase 4
NCT07740655Not Yet Recruiting
Phase 4
Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation...Jeju National University...
NCT07739940
Clinical Research Cohort for Polycystic Ovary SyndromeGuangdong Women and Children HospitalActive Not Recruiting
NCT07739940Active Not Recruiting
—
Clinical Research Cohort for Polycystic Ovary SyndromeGuangdong Women and Child...
NCT07739225
Patient-Centered Education After Hip Fracture SurgeryAssiut UniversityNot Yet RecruitingNot Applicable
NCT07739225Not Yet Recruiting
Not Applicable
Patient-Centered Education After Hip Fracture SurgeryAssiut University
NCT07739043
NeuroRise: Intrathecal CE-1 Treatment for Traumatic SCICell Therapy LLCNot Yet RecruitingEarly Phase 1
NCT07739043Not Yet Recruiting
Early Phase 1
NeuroRise: Intrathecal CE-1 Treatment for Traumatic SCICell Therapy LLC
NCT07739888
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral AnticoagulationNovartis PharmaceuticalsNot Yet RecruitingPhase 3
NCT07739888Not Yet Recruiting
Phase 3
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients Wi...Novartis Pharmaceuticals
NCT07739069
Action Observation Versus Mirror Therapy in Children With Spastic Hemiplegic Cerebral PalsyCairo UniversityNot Yet RecruitingNot Applicable
NCT07739069Not Yet Recruiting
Not Applicable
Action Observation Versus Mirror Therapy in Children With Spastic Hemiplegic Cer...Cairo University
NCT07739134
Multimodal Tracking of Therapy Activity and Effort During RehabilitationETH ZurichActive Not Recruiting
NCT07739134Active Not Recruiting
—
Multimodal Tracking of Therapy Activity and Effort During RehabilitationETH Zurich
NCT07738562
Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological EffectsHadassah Medical OrganizationNot Yet RecruitingPhase 1
NCT07738562Not Yet Recruiting
Phase 1
Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmac...Hadassah Medical Organiza...
NCT07738224
Using the Babble Boot Camp© Speech Therapy Approach With Babies Born PrematurelyMurdoch Childrens Research InstituteNot Yet RecruitingNot Applicable
NCT07738224Not Yet Recruiting
Not Applicable
Using the Babble Boot Camp© Speech Therapy Approach With Babies Born PrematurelyMurdoch Childrens Researc...
NCT07739017
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed GlioblastomaCurtana Pharmaceuticals, Inc.Not Yet RecruitingPhase 1
NCT07739017Not Yet Recruiting
Phase 1
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed GlioblastomaCurtana Pharmaceuticals,...
NCT07740395
Connecting Loved Ones to Support and Empowering RecoveryRhode Island HospitalRecruitingNot Applicable
NCT07740395Recruiting
Not Applicable
Connecting Loved Ones to Support and Empowering RecoveryRhode Island Hospital
NCT07740499
TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel DiseaseIRCCS San RaffaeleNot Yet Recruiting
NCT07740499Not Yet Recruiting
—
TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammator...IRCCS San Raffaele
NCT07738601
Patient Reported Outcome Measurement Within the Secured Access to Innovative Medicines for Children With cAncer (SACHA) StudyAssistance Publique Hopitaux De MarseilleNot Yet Recruiting
NCT07738601Not Yet Recruiting
—
Patient Reported Outcome Measurement Within the Secured Access to Innovative Med...Assistance Publique Hopit...
NCT07739303
Anterior Suprascapular and Axillary vs. Interscalene Block for Analgesia and Diaphragmatic Function in Shoulder SurgeryAnkara Etlik City HospitalNot Yet RecruitingNot Applicable
NCT07739303Not Yet Recruiting
Not Applicable
Anterior Suprascapular and Axillary vs. Interscalene Block for Analgesia and Dia...Ankara Etlik City Hospita...
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07739004
Triage Performance and Physiological Predictors of Serious Illness in Febrile Children in the Pediatric Emergency DepartmentAdana City Training and Research HospitalNot Yet Recruiting
NCT07739004Not Yet Recruiting
—
Triage Performance and Physiological Predictors of Serious Illness in Febrile Ch...Adana City Training and R...
Result Breakdown
Not yet recruiting15 (75%)
Completed2 (10%)
Active, not recruiting2 (10%)
Recruiting1 (5%)
not_applicable9 (45%)
Not Specified6 (30%)
Phase 12 (10%)
Phase 41 (5%)
Early Phase 11 (5%)
Phase 31 (5%)